<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Example of methotrexate treatment protocols for tubal or interstitial ectopic pregnancy&lt;sup&gt;[1-3]&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Example of methotrexate treatment protocols for tubal or interstitial ectopic pregnancy<sup>[1-3]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Example of methotrexate treatment protocols for tubal or interstitial ectopic pregnancy<sup>[1-3]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup width="16%"></colgroup> <colgroup span="3" width="28%"></colgroup> <tbody> <tr> <td class="subtitle1_left" colspan="4">Pretreatment testing and instructions</td> </tr> <tr> <td class="indent1" colspan="4"> <ul> <li>hCG concentration</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="4"> <ul> <li>Transvaginal ultrasound</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="4"> <ul> <li>Blood group and RhD typing (with administration of anti-D immune globulin to RhD-negative patients), if indicated</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="4"> <ul> <li>Complete blood count</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="4"> <ul> <li>Liver and renal function tests</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="4"> <ul> <li>Discontinue folic acid supplements</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="4"> <ul> <li>Counsel patient to avoid nonsteroidal anti-inflammatory medications, recommend acetaminophen if an analgesic is needed</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="4"> <ul> <li>Advise patient to refrain from sexual intercourse and strenuous exercise</li> </ul> </td> </tr> <tr> <td class="subtitle1_left">Treatment day</td> <td class="subtitle1_left">Single-dose protocol<sup>*</sup></td> <td class="subtitle1_left">Two-dose protocol<sup>*</sup></td> <td class="subtitle1_left">Multiple-dose protocol</td> </tr> <tr> <td class="indent1">1</td> <td> <ul> <li>Measure hCG concentration</li> <li>Give <strong>first</strong> dose methotrexate 50 mg/m<sup>2</sup> BSA IM</li> </ul> </td> <td> <ul> <li>Measure hCG concentration</li> <li>Give <strong>first</strong> dose methotrexate 50 mg/m<sup>2</sup> BSA IM</li> </ul> </td> <td> <ul> <li>Measure hCG concentration</li> <li>Give <strong>first</strong> dose methotrexate <strong>1 mg/kg</strong> body weight IM or IV</li> </ul> </td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent1">2</td> <td>–</td> <td>–</td> <td> <ul> <li>Leucovorin 0.1 mg/kg IM<sup>¶</sup></li> </ul> </td> </tr> <tr> <td class="indent1">3</td> <td>–</td> <td>–</td> <td> <ul> <li>Measure hCG concentration</li> <li>If &lt;15% hCG decline from day 1 to 3, give <strong>second</strong> dose methotrexate <strong>1 mg/kg</strong> IM or IV</li> <li>If ≥15% decline from day 1 to 3, draw hCG concentration weekly until undetectable</li> </ul> </td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent1">4</td> <td> <ul> <li>Measure hCG concentration<sup>Δ</sup></li> </ul> </td> <td> <ul> <li>Measure hCG concentration<sup>Δ</sup></li> <li>Give <strong>second</strong> dose methotrexate 50 mg/m<sup>2</sup> IM</li> </ul> </td> <td> <ul> <li>Leucovorin 0.1 mg/kg IM<sup>¶</sup></li> </ul> </td> </tr> <tr> <td class="indent1">5</td> <td>–</td> <td>–</td> <td> <ul> <li>Measure hCG concentration</li> <li>If &lt;15% decline from day 3 to 5, give <strong>third</strong> dose methotrexate <strong>1 mg/kg</strong> IM or IV</li> <li>If ≥15% decline from day 3 to 5, draw hCG concentration weekly until undetectable</li> </ul> </td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent1">6</td> <td>–</td> <td>–</td> <td> <ul> <li>Leucovorin 0.1 mg/kg IM<sup>¶</sup></li> </ul> </td> </tr> <tr> <td class="indent1">7</td> <td> <ul> <li>Measure hCG concentration</li> <li>If &lt;15% hCG decline from day 4 to 7, give <strong>second</strong> dose of methotrexate 50 mg/m<sup>2</sup> IM</li> <li>If ≥15% hCG decline from day 4 to 7, draw hCG concentration weekly until hCG is undetectable</li> </ul> </td> <td> <ul> <li>Measure hCG concentration</li> <li>If &lt;15% decline from day 4 to 7, give <strong>third</strong> dose methotrexate 50 mg/m<sup>2</sup> IM</li> <li>If ≥15% decline, draw hCG concentration weekly until undetectable</li> </ul> </td> <td> <ul> <li>Measure hCG concentration</li> <li>If &lt;15% decline from day 5 to 7, give <strong>fourth</strong> dose methotrexate <strong>1 mg/kg</strong> IM or IV</li> <li>If ≥15% decline from day 5 to 7, draw hCG concentration weekly until undetectable</li> </ul> </td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent1">8</td> <td>–</td> <td>–</td> <td> <ul> <li>Leucovorin 0.1 mg/kg IM<sup>¶</sup></li> </ul> </td> </tr> <tr> <td class="indent1">11</td> <td>–</td> <td> <ul> <li>Measure hCG concentration</li> <li>If &lt;15% decline from day 7 to 11, give <strong>fourth</strong> dose methotrexate 50 mg/m<sup>2</sup> IM</li> <li>If ≥15% decline from day 7 to 11, draw hCG concentration weekly until undetectable</li> </ul> </td> <td>–</td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent1">14</td> <td> <ul> <li>Measure hCG concentration</li> <li>If &lt;15% hCG decline from day 7 to 14, give additional dose of methotrexate 50 mg/m<sup>2</sup> IM<sup>◊</sup></li> <li>If ≥15% hCG decline from day 7 to 14, draw hCG concentration weekly until undetectable</li> </ul> </td> <td> <ul> <li>Measure hCG concentration</li> <li>If &lt;15% hCG decline from day 11 to 14, consider surgical management</li> <li>If ≥15% hCG decline from day 11 to 14, draw hCG concentration weekly until undetectable</li> </ul> </td> <td> <ul> <li>Measure hCG concentration</li> <li>If &lt;15% hCG decline from day 7 to 14, give <strong>fifth</strong> dose of methotrexate <strong>1 mg/kg</strong> IM or IV<sup>◊</sup></li> <li>If ≥15% hCG decline from day 7 to 14, draw hCG concentration weekly until undetectable</li> </ul> </td> </tr> <tr> <td class="indent1">15</td> <td>–</td> <td>–</td> <td> <ul> <li>Leucovorin 0.1 mg/kg IM<sup>¶</sup></li> </ul> </td> </tr> <tr> <td class="indent1">21</td> <td> <ul> <li>Measure hCG concentration</li> <li>If three doses have been given and there is a &lt;15% hCG decline from day 14 to 21, proceed with surgical management</li> </ul> </td> <td>–</td> <td> <ul> <li>Measure hCG concentration</li> <li>If 5 doses have been given and there is a &lt;15% hCG decline from day 14 to 21, proceed with surgical management</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="4">Perform surgery if</td> </tr> <tr> <td class="indent1" colspan="4"> <ul> <li>Severe abdominal pain or an acute abdomen suggestive of tubal rupture</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="4"> <ul> <li>Ultrasonography findings are suggestive of hemoperitoneum</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd"><p>This table is an example; protocols may vary based on provider or institutional preference.</p>
    A calculator useful for determining BSA from patient height and body weight is available separately in UpToDate.</div><div class="graphic_footnotes"><p>hCG: human chorionic gonadotropin beta-subunit; IM: intramuscularly; BSA: body surface area; IV: intravenously.</p>
<p>* Regimens named for the <strong>intended</strong> number of doses versus the actual number of doses given.</p>
<p>¶ Leucovorin is given only if methotrexate was given on the previous day. While leucovorin is typically administered IM for this indication, it can also be given orally. Leucovorin calcium is the preparation used for this indication.</p>
<p>Δ It is common to observe an increase in hCG levels from day 1 through day 4 due to continued hCG production by syncytiotrophoblasts despite cessation of production by cytotrophoblasts; this should not cause concern.</p>
    ◊ Surgical management may be a reasonable option and depends on patient and provider preference.</div><div class="graphic_reference">References:
    <ol>
<li>Alur-Gupta S, Cooney LG, Senapati S. Two-dose versus single-dose methotrexate for treatment of ectopic pregnancy: a meta-analysis. Am J Obstet Gynecol 2019; 221:95.</li>
<li>Barnhart KT. Clinical practice. Ectopic pregnancy. N Engl J Med 2009; 361:379.</li>
<li>American College of Obstetricians and Gynecologists' Committee on Practice Bulletins–Gynecology. ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy. Obstet Gynecol 2018; 131:e91. Reaffirmed 2022.</li>
</ol></div><div id="graphicVersion">Graphic 56738 Version 10.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
